UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000037497
Receipt number R000042744
Scientific Title Study of the pancreatic endocrine and exocrine insufficiency after pancreatic resection
Date of disclosure of the study information 2019/08/01
Last modified on 2023/10/02 18:56:14

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study of the pancreatic endocrine and exocrine insufficiency after pancreatic resection

Acronym

Study of the pancreatic endocrine and exocrine insufficiency after pancreatic resection

Scientific Title

Study of the pancreatic endocrine and exocrine insufficiency after pancreatic resection

Scientific Title:Acronym

Study of the pancreatic endocrine and exocrine insufficiency after pancreatic resection

Region

Japan


Condition

Condition

Pancreatic endocrine and exocrine insufficiency after pancreatic resection

Classification by specialty

Hepato-biliary-pancreatic surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To clarify the pancreatic endocrine and exocrine insufficiency after pancreatic resection.

Basic objectives2

Others

Basic objectives -Others

To clarify the changes of body density and body composition after pancreatic resection.

Trial characteristics_1

Confirmatory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The incidence of pancreatic endocrine and exocrine insufficiency after pancreatic resection

Key secondary outcomes

The changes of body density and body composition after pancreatic resection


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

90 years-old >=

Gender

Male and Female

Key inclusion criteria

Patients who have received pancreatic resection in the past

Key exclusion criteria

1.Patients who have recurrence of the primary tumor.
2.patients with liver cirrhosis or active hepatitis
3.Patients with chronic renal failure requiring dialysis
4.Patients with other malignant disease
5.Patients who are diagnosed to be ineligible by the investigator

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Akio
Middle name
Last name Saiura

Organization

Juntendo University School of Medicine

Division name

Department of Hepatobiliary-Pancreatic Surgery

Zip code

113-8421

Address

2-1-1,hongo,bunnkyouku,tokyo,japan

TEL

03-3813-3111

Email

a-saiura@juntendo.ac.jp


Public contact

Name of contact person

1st name Hirofumi
Middle name
Last name Ichida

Organization

Juntendo University School of Medicine

Division name

Department of Hepatobiliary-Pancreatic Surgery

Zip code

113-8421

Address

2-1-1,hongo,bunnkyouku,tokyo,japan

TEL

03-3813-3111

Homepage URL


Email

hichida@juntendo.ac.jp


Sponsor or person

Institute

Juntendo University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Juntendo University School of Medicine

Address

2-1-1,hongo,bunnkyouku,tokyo,japan

Tel

03-3813-3111

Email

hichida@juntendo.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2019 Year 08 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2019 Year 05 Month 01 Day

Date of IRB

2019 Year 05 Month 24 Day

Anticipated trial start date

2019 Year 05 Month 24 Day

Last follow-up date

2024 Year 05 Month 24 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

This study is to clarify the pancreatic endocrine and exocrine insufficiency after pancreatic resection by 1.questionnaire, 2.blood exam test, 3.PFD test, 4.bone mineral quantitative inspection, 5.InBody (body composition).


Management information

Registered date

2019 Year 07 Month 25 Day

Last modified on

2023 Year 10 Month 02 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000042744


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name